---
annotation-target: Bulletin_pdf.pdf
---


>%%
>```annotation-json
>{"created":"2022-09-23T08:02:12.432Z","updated":"2022-09-23T08:02:12.432Z","document":{"title":"Jcpsp.pk","link":[{"href":"urn:x-pdf:f925c36538ffb80169db04238af5356b"},{"href":"vault:/hematology-theroy/papers/leukemiaWithParaplegia/Bulletin_pdf.pdf"}],"documentFingerprint":"f925c36538ffb80169db04238af5356b"},"uri":"vault:/hematology-theroy/papers/leukemiaWithParaplegia/Bulletin_pdf.pdf","target":[{"source":"vault:/hematology-theroy/papers/leukemiaWithParaplegia/Bulletin_pdf.pdf","selector":[{"type":"TextPositionSelector","start":2480,"end":3015},{"type":"TextQuoteSelector","exact":"The reported incidence of MTX-induced leukoencephalopathy(LE) varies from 0.5% to 3%. Common clinical presentationsinclude  transient  stroke-like  symptoms,  visual  disturbances,and aphasia. These symptoms frequently follow a waxing andwaning  pattern.  Characteristic  radiologic  findings  include  adiffuse high signal in centrum semiovale and deep white matteron MRI T2 and FLAIR sequences. Treatments with folinic acid,dextromethorphan,  aminophylline,  and  methylprednisoloneare effective in the management of MTX-induced LE.2","prefix":"avenous MTX andintrathecal MTX.1","suffix":"Correspondence  to:  Dr.  Jahanz"}]}]}
>```
>%%
>*%%PREFIX%%avenous MTX andintrathecal MTX.1%%HIGHLIGHT%% ==The reported incidence of MTX-induced leukoencephalopathy(LE) varies from 0.5% to 3%. Common clinical presentationsinclude  transient  stroke-like  symptoms,  visual  disturbances,and aphasia. These symptoms frequently follow a waxing andwaning  pattern.  Characteristic  radiologic  findings  include  adiffuse high signal in centrum semiovale and deep white matteron MRI T2 and FLAIR sequences. Treatments with folinic acid,dextromethorphan,  aminophylline,  and  methylprednisoloneare effective in the management of MTX-induced LE.2== %%POSTFIX%%Correspondence  to:  Dr.  Jahanz*
>%%LINK%%[[#^2nqjgkn9iek|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^2nqjgkn9iek
